PubMed

The potentially poor response to outpatient diabetes care in urban African-Americans.

Cook CB, Lyles RH, El-Kebbi I, Ziemer DC, Gallina DL, Dunbar VG, Phillips LS.

Diabetes Care. 2001 Feb;24(2):209-15.PMID: 11213867 [PubMed - indexed for MEDLINE]Related articlesFree article

Diabetes in urban African-Americans. XVI. Overcoming clinical inertia improves glycemic control in patients with type 2 diabetes.

Cook CB, Ziemer DC, El-Kebbi IM, Gallina DL, Dunbar VG, Ernst KL, Phillips LS.

Diabetes Care. 1999 Sep;22(9):1494-500.PMID: 10480515 [PubMed - indexed for MEDLINE]Related articlesFree article

Ethnic differences in the glycemic response to exogenous insulin treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM).

Agrawal L, Emanuele NV, Abraira C, Henderson WG, Levin SR, Sawin CT, Silbert CK, Nuttall FQ, Comstock JP, Colwell JA.

Diabetes Care. 1998 Apr;21(4):510-5.PMID: 9571333 [PubMed - indexed for MEDLINE]Related articlesFree article

Troglitazone add-on therapy to a combination of sulfonylureas plus metformin achieved and sustained effective diabetes control.

Gavin LA, Barth J, Arnold D, Shaw R.

Endocr Pract. 2000 Jul-Aug;6(4):305-10.PMID: 11242607 [PubMed - indexed for MEDLINE]Related articles

The impact of outpatient diabetes management on serum lipids in urban African-Americans with type 2 diabetes.

Erdman DM, Cook CB, Greenlund KJ, Giles WH, El-Kebbi I, Ryan GJ, Gallina DL, Ziemer DC, Dunbar VG, Phillips LS.

Diabetes Care. 2002 Jan;25(1):9-15.PMID: 11772894 [PubMed - indexed for MEDLINE]Related articlesFree article

Near-normoglycaemic remission in African-Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function.

McFarlane SI, Chaiken RL, Hirsch S, Harrington P, Lebovitz HE, Banerji MA.

Diabet Med. 2001 Jan;18(1):10-6.PMID: 11168335 [PubMed - indexed for MEDLINE]Related articles

Prognostic factors for successful insulin therapy in subjects with type 2 diabetes.

Wolffenbuttel BH, Sels JP, Rondas-Colbers GJ, Menheere PP.

Neth J Med. 1999 Feb;54(2):63-9.PMID: 10079680 [PubMed - indexed for MEDLINE]Related articles

Patient characteristics do not predict poor glycaemic control in type 2 diabetes patients treated in primary care.

Goudswaard AN, Stolk RP, Zuithoff P, Rutten GE.

Eur J Epidemiol. 2004;19(6):541-5.PMID: 15330126 [PubMed - indexed for MEDLINE]Related articles

Diabetes in urban African Americans. III. Management of type II diabetes in a municipal hospital setting.

Ziemer DC, Goldschmid MG, Musey VC, Domin WS, Thulé PM, Gallina DL, Phillips LS.

Am J Med. 1996 Jul;101(1):25-33.PMID: 8686711 [PubMed - indexed for MEDLINE]Related articles

Diabetes in urban African-Americans. IX. Provider adherence to management protocols.

el-Kebbi IM, Ziemer DC, Musey VC, Gallina DL, Bernard AM, Phillips LS.

Diabetes Care. 1997 May;20(5):698-703.PMID: 9135929 [PubMed - indexed for MEDLINE]Related articles

Sulfonylurea treatment prevents recurrence of hyperglycemia in obese African-American patients with a history of hyperglycemic crises.

Umpierrez GE, Clark WS, Steen MT.

Diabetes Care. 1997 Apr;20(4):479-83.PMID: 9096964 [PubMed - indexed for MEDLINE]Related articles

Long-term efficacy of triple oral therapy for type 2 diabetes mellitus.

Bell DS, Ovalle F.

Endocr Pract. 2002 Jul-Aug;8(4):271-5.PMID: 12173913 [PubMed - indexed for MEDLINE]Related articles

Racial and ethnic differences in health care access and health outcomes for adults with type 2 diabetes.

Harris MI.

Diabetes Care. 2001 Mar;24(3):454-9.PMID: 11289467 [PubMed - indexed for MEDLINE]Related articlesFree article

The pattern of dyslipidemia among urban African-Americans with type 2 diabetes.

Cook CB, Erdman DM, Ryan GJ, Greenlund KJ, Giles WH, Gallina DL, El-Kebbi IM, Ziemer DC, Ernst KL, Dunbar VG, Phillips LS.

Diabetes Care. 2000 Mar;23(3):319-24.PMID: 10868858 [PubMed - indexed for MEDLINE]Related articlesFree article

Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial.

Derosa G, Cicero AF, Gaddi A, Ragonesi PD, Fogari E, Bertone G, Ciccarelli L, Piccinni MN.

Clin Ther. 2004 May;26(5):744-54.PMID: 15220018 [PubMed - indexed for MEDLINE]Related articles

Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.

Tîrgovişte CI, Străchinariu R, Farcaşiu E, Milicevic Z, Teodorescu G.

Rom J Intern Med. 2003;41(2):153-62.PMID: 15526500 [PubMed - indexed for MEDLINE]Related articles

Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide.

Roach, Koledova E, Metcalfe S, Hultman C, Milicevic Z; Romania/Russia Mix25 Study Group.

Clin Ther. 2001 Oct;23(10):1732-44.PMID: 11726007 [PubMed - indexed for MEDLINE]Related articles

Poor glycemic control increases risk of hospitalization in urban African Americans with diabetes.

Cook CB, Hentz JG, Tsui C, Ziemer DC, Naylor DB, Miller WJ.

Ethn Dis. 2006 Autumn;16(4):880-5.PMID: 17061741 [PubMed - indexed for MEDLINE]Related articles

Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55).

Davis TM, Cull CA, Holman RR; U.K. Prospective Diabetes Study (UKPDS) Group.

Diabetes Care. 2001 Jul;24(7):1167-74.PMID: 11423497 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.

Derosa G, Cicero AF, Gaddi AV, Ciccarelli L, Piccinni MN, Salvadeo S, Pricolo F, Fogari E, Ghelfi M, Ferrari I, Fogari R.

Clin Ther. 2005 Sep;27(9):1383-91.PMID: 16291411 [PubMed - indexed for MEDLINE]Related articles